Successful Dose De-Escalation of Infliximab in Rheumatoid Arthritis Patients with Stable Low Disease Activity and Treatment

被引：0
作者：
van der Maas, Aatke
den Broeder, Alfons
van den Hoogen, Frank H. J. [1 ]
Van Riel, Piet [2 ]
van den Bemt, Bart J. F.
机构：
[1] Sint Maartensklini, Dept Rheumatol, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1700
引用
收藏
页码：S666 / S666
页数：1
相关论文
共 50 条
  • [41] EFFECT OF DOSE ESCALATION OF SUBCUTANEOUS TOCILIZUMAB ON DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS IN A RANDOMIZED CONTROLLED TRIAL
    Singer, N.
    Mohan, S.
    Han, J.
    Edwardes, M.
    Michalska, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1126 - 1126
  • [42] Infliximab De-escalation in Patients With Crohn's Disease in Clinical Remission Is Safe and Well-tolerated
    Allegretti, Jessica R.
    Canakis, Andrew
    McClure, Emma
    Marcus, Jenna
    Norton, Beth-Ann
    Hamilton, Matthew J.
    Winter, Rachel W.
    De Silva, Punyanganie S.
    Friedman, Sonia
    Korzenik, Joshua R.
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (12) : 2031 - 2033
  • [43] Letter: infliximab de-escalation based on trough levels in patients with inflammatory bowel disease - authors' reply
    Chaparro, M.
    Gisbert, J. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (07) : 940 - 941
  • [44] Dose Reduction Of Tocilizumab In Rheumatoid Arthritis Patients With Low Disease Activity Is Feasible
    van Herwaarden, Noortje
    Herfkens-Hol, Susan
    van der Maas, Aatke
    van Den Bemt, Bart J. F.
    van Vollenhoven, Ronald F.
    Bijlsma, Johannes W. J.
    den Broeder, Alfons A.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S992 - S992
  • [45] De-escalation of axillary treatment in neoadjuvant setting: recommendations for a successful work
    Franceschini, Gianluca
    Di Leone, Alba
    D'Archi, Sabatino
    Masetti, Riccardo
    MINERVA SURGERY, 2021, 76 (03): : 288 - 289
  • [46] FACTORS ASSOCIATED WITH BIOLOGIC TREATMENT DE-ESCALATION IN PATIENTS WITH CROHN'S DISEASE
    Lien, P. W.
    Lee, T. A.
    VALUE IN HEALTH, 2024, 27 (06) : S38 - S38
  • [47] Successful treatment of infliximab-refractory rheumatoid arthritis with rituximab
    Tuscano, JM
    ARTHRITIS AND RHEUMATISM, 2002, 46 (12): : 3420 - 3420
  • [48] Pharmacist Driven De-Escalation of Inhaled Corticosteroids in Patients with Stable Chronic Obstructive Pulmonary Disease
    Melzer, A. C.
    Bolduc, J.
    Chezik, L. R.
    Kunisaki, K. M.
    Hegland, A. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [49] DOSE DE-ESCALATION WITH GAMMA KNIFE RADIOSURGERY IN THE TREATMENT OF CHOROIDAL MELANOMA
    Schirmer, Clemens M.
    Chan, Michael
    Mignano, John
    Duker, Jay
    Melhus, Christopher S.
    Williams, Lloyd B.
    Wu, Julian K.
    Yao, Kevin C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (01): : 170 - 176
  • [50] Comparison of Dose Escalation and Co-therapy Intensification between Patients with Rheumatoid Arthritis Initiating Biologic Treatment with Etanercept, Adalimumab and Infliximab
    Thorne, Carter
    Boire, Gilles
    Chow, Andrew
    Garces, Kirsten
    Poulin-Costello, Melanie
    Walker, Valery
    Haraoui, Boulos
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1171 - 1171
12345